OncoDNA appoints Dr Bernard Courtieu as Chief Executive Officer

January 25th 2021


OncoDNA, has announced today that it has appointed Bernard Courtieu, previously CEO of IntegraGen, as Chief Executive Officer. Dr Courtieu joined IntegraGen as CEO in 2007. Prior to joining the company, he achieved significant success in the role of Practice Leader and later as Vice President within Gemini Consulting’s Life Sciences Division in France, improving the operational performance of pharmaceutical companies in the fields of research and development, industrial operations, supply, sales and marketing and information systems. Please, disciver the press release here.